November 21, 2026
$RichWire Markets and money, explained simply
LIVE
Walmart Shares Waver Despite Topping Estimates as Growth Momentum Cools Bitcoin Slips Below Key Support Level as Bearish Technical Structure Takes Hold Bitcoin Tests Support Following Drop Below $60,000 Milestone Evaluating HF Sinclair and the Turning Oil Refining Cycle Bitcoin Technical Outlook Signals Persistent Bearish Structure Despite Short-Term Bounce Mapping Out a $500 Stake in Two Emerging Quantum Computing Enterprises Bitcoin Eyes Resistance Near $61,800 Following Support Bounce Analyst Suggests Taking Profits on Global X MSCI Colombia ETF Anthropic IPO Momentum Fades as Stock Slips Below Opening Levels Bitcoin Tests Critical Monthly Support Level as Traders Watch for Breakdown or Rebound Bitcoin Tests $58,000 Put Wall Following Market Flush CG Oncology Fair Value Revised Following Phase 3 Clinical Results Walmart Shares Waver Despite Topping Estimates as Growth Momentum Cools Bitcoin Slips Below Key Support Level as Bearish Technical Structure Takes Hold Bitcoin Tests Support Following Drop Below $60,000 Milestone Evaluating HF Sinclair and the Turning Oil Refining Cycle Bitcoin Technical Outlook Signals Persistent Bearish Structure Despite Short-Term Bounce Mapping Out a $500 Stake in Two Emerging Quantum Computing Enterprises Bitcoin Eyes Resistance Near $61,800 Following Support Bounce Analyst Suggests Taking Profits on Global X MSCI Colombia ETF Anthropic IPO Momentum Fades as Stock Slips Below Opening Levels Bitcoin Tests Critical Monthly Support Level as Traders Watch for Breakdown or Rebound Bitcoin Tests $58,000 Put Wall Following Market Flush CG Oncology Fair Value Revised Following Phase 3 Clinical Results

UnitedHealth Group Targets Long-Term Earnings Growth of Up to 16%

📈 Markets 2 min read 👁 4

UnitedHealth Group has reaffirmed its long-term earnings growth forecast of 13% to 16%, supported by a strong performance in its Optum division and operational improvements.

UnitedHealth Group Targets Long-Term Earnings Growth of Up to 16%📈Markets

Photo: Motley Fool

Key points

  • UnitedHealth reiterated a 13% to 16% long-term earnings growth target.
  • Optum division growth is fueled by AI integration and value-based care models.
  • Full-year 2026 adjusted earnings guidance was raised to at least $20.50 per share.

UnitedHealth Group is projecting significant long-term growth, reiterating a target of 13% to 16% annual earnings expansion during its recent earnings call. This outlook follows a strong third quarter in 2026, where the company reported $112.7 billion in revenue and adjusted earnings of $4.69 per share. Management has subsequently raised its full-year 2026 adjusted earnings guidance to a minimum of $20.50 per share, signaling confidence in its ongoing turnaround strategy.

A primary driver for this growth is the company's Optum business, which integrates pharmacy services, data analytics, and healthcare delivery. By shifting toward value-based care models and leveraging artificial intelligence to streamline clinical workflows—such as AI-enabled chart summarization—UnitedHealth aims to improve operational efficiency and patient outcomes. The company reports that these AI tools have already reduced chart review times by approximately 33% for over 40% of its clinicians.

Despite this optimistic outlook, the company faces persistent challenges, including rising medical costs for complex patient populations and ongoing regulatory scrutiny regarding Medicare Advantage reimbursements and pharmacy benefit management. Investors are weighing these risks against the potential for earnings to compound significantly over the next five years, with some projections suggesting a target price range between $422 and $947 by 2031 depending on valuation multiples.

What to watch next: Monitor future quarterly reports for signs of margin expansion and any updates on regulatory impacts to the Medicare Advantage business.

Source Motley Fool — fool.com/investing/2026/11/18/unitedhealth-is-targeting-13-to-16-lo… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.